Leslie Citrome, MD, MPH, is Clinical Professor of Psychiatry and Behavioral Sciences at New York Medical College in Valhalla, NY and has a private practice in Pomona, NY. He is a member of the Board of Directors of the American Society of Clinical Psychopharmacology and the Mental Health Association of Rockland County. Dr. Citrome was the founding Director of the Clinical Research and Evaluation Facility at the Nathan S. Kline Institute for Psychiatric Research, and after nearly two decades of government service as a researcher in the psychopharmacological treatment of severe mental disorders, he works as a consultant in clinical trial design and interpretation. He is a frequent lecturer on the quantitative assessment of clinical trial results using the evidence-based medicine metrics of "number needed to treat" and "number needed to harm."
Dr. Citrome graduated from the McGill University Faculty of Medicine and completed a residency and chief residency in psychiatry at the New York University School of Medicine. He went on to complete a Masters in Public Health from the Columbia University School of Public Health.
Dr. Citrome's primary research interests have centered on psychopharmacologic approaches to schizophrenia, bipolar disorder, and major depressive disorder. He is the author or co-author of more than 400 published research reports, reviews, and book chapters, is the Editor-in-Chief for the International Journal of Clinical Practice, serves on the editorial board of 11 medical journals, reviews for more than 90 journals, and has lectured extensively throughout the USA, Canada, Europe, and Asia. He is also the author of the book, Handbook of Treatment-Resistant Schizophrenia, published in 2013 by Springer Healthcare.